RXST: rxsight.com Company Buyout Price

RXST (RxSight Ophthalmic) - company brandmark

This chart of RxSight, Inc. (RXST) valuation history illustrates the Enterprise Value dynamics, which currently stands at 5.58. The business is transforming ophthalmology by implementing LAL adaptive lenses and expanding its network of laser systems to ensure stable revenue. The team led by Ron Kurtz is effectively increasing market reach, demonstrating precision in the execution of innovations. The environmental profile is limited to compliance with medical standards and packaging optimization.

RXST (RxSight Corp) Total Company Value history from 11/23/2025 to 10/28/2026

Financial and market metric breakdowns for RxSight, Inc. (RXST)

- price and consensus price forecast:
Share Price RxSight Inc|RXST - Price Target Chart
- market capitalization data:
Market Capitalization RxSight|RXST - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share RxSight|RXST - Company Book Value|Market Capitalization to Book Value rxsight.com|RXST - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity RxSight, Inc.|RXST - Long-Term Debt to Capital|Current Liabilities to Capital rxsight.com|RXST - Company Aggregate Debts|Debt to Book Value RxSight
Fundamental company valuation:RXST (RxSight Inc)
Original product of RxSight Corp

Enterprise Value (EV) reflects the total acquisition cost of a business, summing market capitalization and net debt to eliminate the impact of financing structure. By analyzing the Enterprise Value trend, an investor can discern the real asset value of RxSight, Inc., which, amid scaling lens sales and reducing unit costs, becomes a key indicator of the company's operating leverage efficiency.

Competing companies

Boston Scientific Corp - Business Value|Total Company Value EW (Edwards Lifesciences Corp)|ResMed Corporation (RMD) - Company Buyout Price|PODD - Real Price to Acquire Entire Company|ZBH (Zimmer Biomet Holdings) - Aggregate Business Value|COO: Total Company Value|Company Buyout Price ALGN|GMED - Total Company Value|Full Business Value TransMedics Group Inc (TMDX)|ATEC: Enterprise Value|Total Enterprise Value artivion.com AORT|ENOV: Enterprise Value|IART - Real Price to Acquire Entire Company|Motiva - Enterprise Value|iLet Bionic Pancreas (BBNX) - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value EMBC|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AxoGen Inc (AXGN)|Enterprise Value SIBN|OFIX - Company Buyout Price|Real Price to Acquire Entire Company Bioventus Inc.|KIDS - Full Business Value|Enterprise Value TMCI|Blade Air Mobility (SRTA) - Total Enterprise Value|Enterprise Value Carlsmed Corp (CARL)|Business Value ClearPoint (CLPT)|Stereotaxis, Inc. (STXS) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash STIM (neurostar.com)|Sight Sciences - Total Company Value|Real Price to Acquire Entire Company orchestrabiomed.com OBIO|ANIK (Anika) - Enterprise Value|NSPR - Total Enterprise Value|Enterprise Value zhjmedical.com|Vivani Medical (VANI) - Business Value|XTNT: Enterprise Value|Company Buyout Price NeuroOne|Enterprise Value MODD (Modular Medical)|Real Price to Acquire Entire Company Myomo Inc (MYO)|Enterprise Value COCH (Envoy Medical, Inc.)|vivoslife.com - Enterprise Value|NVNO - Total Company Value|Sintx Technologies (SINT) - Total Company Value|Real Price to Acquire Entire Company Tenon Medical, Inc TNON|Lifeward Ltd. (LFWD) - Value Adjusted for Debt and Cash|Enterprise Value AMIX (Autonomix Medical Inc.)|Total Enterprise Value IVF|BBLG: Total Company Value|Full Takeover Company Value Axonics Inc. AXNX|Real Price to Acquire Entire Company BIOL (Biolase, Inc.)|Enterprise Value Dynatronics Corp DYNT|Enterprise Value FNA (Paragon 28 Corp)|INVO: Company Buyout Price